| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +3701.4% |
| Cost of Revenue | $818K | — |
| Gross Profit | $1.1M | +2390.3% |
| R&D Expense | $789K | -25.2% |
| SG&A Expense | $1.4M | +651.6% |
| Operating Income | -$7.1M | -42.2% |
| Interest Expense | $18K | -38.1% |
| Pre-tax Income | -$6.9M | +36.1% |
| Income Tax | $36K | +137.3% |
| Net Income | -$6.9M | +33.4% |
| EPS (Basic) | -$4.83 | -885.7% |
| EPS (Diluted) | -$4.83 | -885.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $707K | +349.8% |
| Accounts Receivable | $37K | +791.1% |
| Inventory | $963K | +785.9% |
| Current Assets | $2.0M | +104.1% |
| Total Assets | $2.4M | +60.6% |
| Current Liabilities | $7.9M | +34.7% |
| Total Liabilities | $8.2M | +33.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | +24.1% |
| Capital Expenditures | $14K | — |
| Investing Cash Flow | -$164K | +78.1% |
| Financing Cash Flow | $4.0M | +69.7% |
| Free Cash Flow | -$3.3M | — |
| -$5.9M |
| -24.5% |